NEUE vs ACRV

Comparison between NeueHealth, Inc. (NEUE, Company) and Acrivon Therapeutics Inc (ACRV, Company).

Both NEUE and ACRV are from the Healthcare sector.

NEUE vs ACRV - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NEUE(COMPANY)	ACRV(COMPANY)
Market Cap	$61M	$61M
Max Drawdown	99.72%	95.47%
Sharpe Ratio	0.52	0.70
5Y Beta	N/A	1.79
Industry	Healthcare Plans	Biotechnology
P/E Ratio	-0.70	-0.67
Debt to Equity	-15.59%	0.00%

Market Cap

Winner

NEUE

$61M

ACRV

$61M

Max Drawdown

NEUE

99.72%

Winner

ACRV

95.47%

Sharpe Ratio

NEUE

0.52

Winner

ACRV

0.70

5Y Beta

NEUE

N/A

ACRV

1.79

Industry

NEUE

Healthcare Plans

ACRV

Biotechnology

P/E Ratio

Winner

NEUE

-0.70

ACRV

-0.67

Debt to Equity

Winner

NEUE

-15.59%

ACRV

0.00%

NEUE vs ACRV - Historical Returns

Returns include dividend reinvestment.

Period	NEUE	ACRV
1 month	+0.49%	-4.85%
3 months	-0.98%	-4.27%
6 months	+1.55%	-30.53%
1 year	+15.63%	+26.61%
5 years(CAGR)	-70.68%	N/A
Max(CAGR)	-70.68%	-48.20%

Winner

NEUE

+0.49%

ACRV

-4.85%

Winner

NEUE

-0.98%

ACRV

-4.27%

Winner

NEUE

+1.55%

ACRV

-30.53%

NEUE

+15.63%

Winner

ACRV

+26.61%

5Y(CAGR)

NEUE

-70.68%

ACRV

N/A

Max(CAGR)

NEUE

-70.68%

Winner

ACRV

-48.20%

NEUE vs ACRV - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

Year	NEUE	ACRV
2026	N/A	-36.18%
2025	-7.87%	-57.64%
2024	-10.06%	+20.16%
2023	-83.11%	-57.48%
2022	-82.53%	-30.77%
2021	-79.33%	N/A

NEUE vs ACRV Drawdown Comparison

The maximum drawdown for NEUE was -99.72%, occurring on Dec 20, 2024. This drawdown has not yet recovered.

The maximum drawdown for ACRV was -95.47%, occurring on May 30, 2025. This drawdown has not yet recovered.

The current NEUE drawdown is -99.51%. The current ACRV drawdown is -93.23%.

Rank	NEUE	ACRV
#1	-99.72% Jun 29, 2021 - Dec 20, 2024	-95.47% Feb 14, 2023 - May 30, 2025
#2	-0.06% Jun 25, 2021 - Jun 29, 2021	-32.24% Nov 16, 2022 - Feb 2, 2023
#3	N/A	-2.62% Feb 8, 2023 - Feb 13, 2023